Glutathione and immune function
暂无分享,去创建一个
[1] E. Beutler. Nutritional and metabolic aspects of glutathione. , 1989, Annual review of nutrition.
[2] W. Dröge,et al. Expression of increased immunogenicity by thiol-releasing tumor variants. , 1992, Cellular immunology.
[3] W. Dröge,et al. Effect of glutathione depletion and oral N‐acetyl‐cysteine treatment on CD4+ and CD8+ cells , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[5] W. Dröge,et al. Glutathione reverses the inhibition of T cell responses by superoptimal numbers of "nonprofessional" antigen presenting cells. , 1994, Cellular immunology.
[6] Ze'ev Ronai,et al. Role of redox potential and reactive oxygen species in stress signaling , 1999, Oncogene.
[7] B. Gazzard,et al. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate. , 1999, American journal of physiology. Endocrinology and metabolism.
[8] W. Dröge,et al. Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. , 1988, Biological chemistry Hoppe-Seyler.
[9] H. Wedner,et al. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. , 1985, Journal of immunology.
[10] W. Dröge,et al. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. , 1990, Cellular immunology.
[11] W. Dröge,et al. Differential effects of glutathione depletion on T cell subsets. , 1991, Cellular immunology.
[12] K. Schulze-Osthoff,et al. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] W. Dröge,et al. N-acetyl-cysteine in the therapy of HIV-positive patients. , 1999, Current opinion in clinical nutrition and metabolic care.
[14] S. Roth,et al. Regulation of interleukin 2 production, interleukin 2 mRNA expression and intracellular glutathione levels in ex vivo derived T lymphocytes by lactate , 1991, European journal of immunology.
[15] M. Roederer,et al. Glutathione deficiency is associated with impaired survival in HIV disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. B. Allison,et al. Some effects of methionine on the utilization of nitrogen in the adult dog. , 1947, The Journal of nutrition.
[17] T. Ishii,et al. Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine , 1987, Journal of cellular physiology.
[18] M. Roederer,et al. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. , 1991, International immunology.
[19] Lutz Edler,et al. Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials , 2000, Journal of Molecular Medicine.
[20] R. Kurth,et al. Inhibition of HIV‐1 replication and NF-x B activity by cysteine and cysteine derivatives , 1991, AIDS.
[21] M. Roederer,et al. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses , 1991 .
[22] Glen,et al. Changes in plasma amino acid concentrations in response to HIV-1 infection. , 1994, Clinical chemistry.
[23] R. Crystal,et al. SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.
[24] E. F. ARMSTRONG,et al. Annual Review of Biochemistry , 1944, Nature.
[25] M. Roederer,et al. Glutathione deficiency and human immunodeficiency virus infection , 1992, The Lancet.
[26] V. Hack,et al. Short Communication: Elevated Hepatic γ-Glutamylcysteine Synthetase Activity and Abnormal Sulfate Levels in Liver and Muscle Tissue May Explain Abnormal Cysteine and Glutathione Levels in SIV-Infected Rhesus Macaques , 1996 .
[27] P. G. Wells,et al. Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV‐infected patients: toxicological and pathological implications , 1997, AIDS.
[28] H. Nakamura,et al. Redox regulation of cellular activation. , 1997, Annual review of immunology.
[29] W. Dröge,et al. Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide. , 1987, Cellular immunology.
[30] W. Dröge,et al. Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. , 1990, Cellular immunology.
[31] B. Lauterburg,et al. Glutathione depletion in HIV‐infected patients: role of cysteine deficiency and effect of oral N‐acetylcysteine , 1992, AIDS.
[32] K. Schulze-Osthoff,et al. IL‐2 gene expression and NF‐kappa B activation through CD28 requires reactive oxygen production by 5‐lipoxygenase. , 1995, The EMBO journal.
[33] D. Baker,et al. CYSTINE IS THE FIRST LIMITING AMINO ACID FOR UTILIZATION OF ENDOGENOUS AMINO ACIDS IN CHICKS FED A PROTEIN-FREE DIET , 1999 .
[34] D. Hart,et al. Enhancement by reducing agents of the transformation of human and rabbit peripheral lymphocytes. , 1970, Journal of immunology.
[35] A. Sönnerborg,et al. Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial , 1996, European Journal of Clinical Pharmacology.
[36] W. Dröge,et al. Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] W. Dröge,et al. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. , 1989, Biological chemistry Hoppe-Seyler.
[38] P. Diaz,et al. Alveolar fluid glutathione decreases in asymptomatic HIV-seropositive subjects over time. , 1997, Chest.
[39] V. Andersen. Cellular Immunology , 2003, Nordisk medicin.
[40] K. Schulze-Osthoff,et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] W. Dröge,et al. Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. , 1994, European journal of biochemistry.
[42] P. Baeuerle,et al. H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.
[43] V. Hack,et al. Cystine levels, cystine flux, and protein catabolism in cancer cachexia, HIV/SIV infection, and senescence , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] H. Eck,et al. Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques , 1991, The Lancet.
[45] A. Meister. Selective modification of glutathione metabolism. , 1983, Science.
[46] J. Yodoi,et al. Massive loss of sulfur in HIV infection. , 2000, AIDS research and human retroviruses.
[47] B. Pastuszewska,et al. Effect of methionine supplementation of a protein-free diet on the nitrogen excretion in rats and pigs. , 2009, Zeitschrift fur Tierphysiologie, Tierernahrung und Futtermittelkunde.
[48] W. Dröge,et al. HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine. , 1992, Immunology today.